| Paul F Barresi, MD | |
|
6 Glen Cove Dr, Rockport, ME 04856 | |
| (207) 596-8000 | |
| Not Available |
| Full Name | Paul F Barresi |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 6 Glen Cove Dr, Rockport, Maine |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770503476 | NPI | - | NPPES |
| 253320099 | Medicaid | ME | |
| 283320099 | Medicaid | ME |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 012155 (Maine) | Primary |
| Entity Name | Waldo County General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841397932 PECOS PAC ID: 2163332883 Enrollment ID: O20040428001058 |
News Archive
Eph receptors and their partner proteins, the ephrins, are vital for intercellular communication.
The Academy of Nutrition and Dietetics has prepared a request to submit to the Centers for Medicare and Medicaid Services (CMS) to expand coverage of medical nutrition therapy (MNT) for specific diseases, including hypertension, obesity, and cancer, as part of the CMS National Coverage Determination (NCD) Process.
Ligand Pharmaceuticals Incorporated today announced that its partner GlaxoSmithKline has announced that it received positive data from ENABLE-1, the first of two Phase III studies examining Promacta in patients with hepatitis C-related thrombocytopenia, and that full data will be released at an upcoming scientific conference.
Young scientists from any European member country of the European Pain Federation EFIC® are invited to apply for the EFIC-Grünenthal Grant (E-G-G) 2014.
QLT Inc. ("QLT" or the "Company") today announced that it has restructured its agreement with Novartis Pharma AG ("Novartis") to simplify the relationship, under which, effective January 1, 2010, it will, among other things, receive exclusive U.S. rights to the Visudyne(R) patents to sell and market Visudyne in the U.S. Visudyne, a photosensitizer co-developed with Novartis, is approved worldwide for the treatment of a form of wet age-related macular degeneration ("AMD"), the leading cause of legal blindness in people over the age of 55 in North America and Europe.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Paul F Barresi, MD Po Box 1849, Lewiston, ME 04241-1849 Ph: (207) 784-2554 | Paul F Barresi, MD 6 Glen Cove Dr, Rockport, ME 04856 Ph: (207) 596-8000 |
News Archive
Eph receptors and their partner proteins, the ephrins, are vital for intercellular communication.
The Academy of Nutrition and Dietetics has prepared a request to submit to the Centers for Medicare and Medicaid Services (CMS) to expand coverage of medical nutrition therapy (MNT) for specific diseases, including hypertension, obesity, and cancer, as part of the CMS National Coverage Determination (NCD) Process.
Ligand Pharmaceuticals Incorporated today announced that its partner GlaxoSmithKline has announced that it received positive data from ENABLE-1, the first of two Phase III studies examining Promacta in patients with hepatitis C-related thrombocytopenia, and that full data will be released at an upcoming scientific conference.
Young scientists from any European member country of the European Pain Federation EFIC® are invited to apply for the EFIC-Grünenthal Grant (E-G-G) 2014.
QLT Inc. ("QLT" or the "Company") today announced that it has restructured its agreement with Novartis Pharma AG ("Novartis") to simplify the relationship, under which, effective January 1, 2010, it will, among other things, receive exclusive U.S. rights to the Visudyne(R) patents to sell and market Visudyne in the U.S. Visudyne, a photosensitizer co-developed with Novartis, is approved worldwide for the treatment of a form of wet age-related macular degeneration ("AMD"), the leading cause of legal blindness in people over the age of 55 in North America and Europe.
› Verified 8 days ago
Dr. Michael K Gowesky, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 6 Glen Cove Drive, Rockport, ME 04856 Phone: 207-596-8000 | |
Robert F Legendre Jr., M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 6 Glen Cove Dr, Rockport, ME 04856 Phone: 207-596-8414 | |
James A Dorsch, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 6 Glen Cove Dr, Rockport, ME 04856 Phone: 207-596-8414 | |
Anthony P. Solley, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 6 Glen Cove Dr, Rockport, ME 04856 Phone: 207-596-8414 | |
David Maddox, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 6 Glen Cove Dr, Rockport, ME 04856 Phone: 207-596-8000 | |
Jennifer Mytar-li, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 6 Glen Cove Dr, Rockport, ME 04856 Phone: 207-301-8000 |